Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the scientific advisory board of the nationals Kidney Foundation from an Ad Hoc Committee of the council on diabetes mel of the national kidney foundation

H. Bennett, Peter; Haffner, Steven; Kasiske, Bertram L.; Keane, William F.; Mogensen, Carl Erik; Parving, Hans-Henrik; Steffes, Michael W.; Striker, Gary E.

« Previous Next »American Journal of Kidney Diseases
Volume 25, Issue 1 , Pages 107-112, January 1995

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the scientific advisory board of the nationals Kidney Foundation from an Ad Hoc Committee of the council on diabetes mel of the national kidney foundation

Peter H. Bennett, MB FRCP FFCM
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA
Steven Haffner, MD
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA
Bertram L. Kasiske, MD
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA
William F. Keane, MD
- Address reprint requests to William F. Keane, MD, Division of Nephrology, Department of Medicine, Hennepin County Medical Center, 701 Park Ave, Minneapolis, MN 55415.
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA
Carl Erik Mogensen, MD
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA
Hans-Henrik Parving, MD
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA
Michael W. Steffes, MD PhD
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA
Gary E. Striker, MD
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA
- Aarhus University Hospital USA
- Steno Diabetes Center, and the University of Minnesota Hospitals and Clinics, University of Minnesota Medical School USA

Received 3 November 1994; accepted 7 November 1994.

Abstract

All individuals with diabetes mellitus should be screened yearly with a spot urine albumin:creatinine ratio to identify those who are at increased risk for the development of complications of diabetes mellitus, including nephropathy, retinopathy, and cardiovascular disease. Once these high-risk individuals are appropriately identified, it is recommended that therapy with an angiotensin-converting enzyme (ACE) inhibitor be initiated. In addition, cardiovascular risk factors should be investigated, and when appropriate, therapeutic interventions should be initiated according to existing recommendations.

No full text is available. To read the body of this article, please view the PDF online.